11/14
04:00 pm
okur
Form SC 13G/A OnKure Therapeutics, Filed by: TANG CAPITAL MANAGEMENT LLC
Low
Report
Form SC 13G/A OnKure Therapeutics, Filed by: TANG CAPITAL MANAGEMENT LLC
11/14
10:12 am
okur
Form SC 13G OnKure Therapeutics, Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Low
Report
Form SC 13G OnKure Therapeutics, Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
11/7
04:21 pm
okur
Form 424B3 OnKure Therapeutics,
Low
Report
Form 424B3 OnKure Therapeutics,
11/7
04:05 pm
okur
Form 8-K OnKure Therapeutics, For: Nov 07
Low
Report
Form 8-K OnKure Therapeutics, For: Nov 07
11/7
04:01 pm
okur
Form 10-Q OnKure Therapeutics, For: Sep 30
Low
Report
Form 10-Q OnKure Therapeutics, For: Sep 30
10/31
04:11 pm
okur
Form 424B3 OnKure Therapeutics,
Medium
Report
Form 424B3 OnKure Therapeutics,
10/31
06:04 am
okur
Form EFFECT OnKure Therapeutics,
Low
Report
Form EFFECT OnKure Therapeutics,
10/28
04:03 pm
okur
Form SC 13G/A OnKure Therapeutics, Filed by: Octagon Capital Advisors LP
Low
Report
Form SC 13G/A OnKure Therapeutics, Filed by: Octagon Capital Advisors LP
10/23
05:04 pm
okur
Form S-1 OnKure Therapeutics,
Medium
Report
Form S-1 OnKure Therapeutics,
10/23
04:16 pm
okur
Form SC 13G/A OnKure Therapeutics, Filed by: Deep Track Capital, LP
Medium
Report
Form SC 13G/A OnKure Therapeutics, Filed by: Deep Track Capital, LP
10/21
02:25 pm
okur
Form D OnKure Therapeutics,
Low
Report
Form D OnKure Therapeutics,
10/16
04:30 pm
okur
Form SC 13G/A OnKure Therapeutics, Filed by: Cormorant Asset Management, LP
Medium
Report
Form SC 13G/A OnKure Therapeutics, Filed by: Cormorant Asset Management, LP
10/15
04:08 pm
okur
Form 3 OnKure Therapeutics, For: Oct 04 Filed by: Cormorant Private Healthcare Fund III LP
Low
Report
Form 3 OnKure Therapeutics, For: Oct 04 Filed by: Cormorant Private Healthcare Fund III LP
10/11
05:24 pm
okur
Form SC 13G OnKure Therapeutics, Filed by: CITADEL ADVISORS LLC
Low
Report
Form SC 13G OnKure Therapeutics, Filed by: CITADEL ADVISORS LLC
10/11
04:23 pm
okur
Form SC 13G OnKure Therapeutics, Filed by: Cormorant Asset Management, LP
Low
Report
Form SC 13G OnKure Therapeutics, Filed by: Cormorant Asset Management, LP
10/11
04:16 pm
okur
Form SC 13G OnKure Therapeutics, Filed by: Samsara BioCapital, L.P.
Low
Report
Form SC 13G OnKure Therapeutics, Filed by: Samsara BioCapital, L.P.
10/11
04:00 pm
okur
Form SC 13G OnKure Therapeutics, Filed by: Deep Track Capital, LP
Low
Report
Form SC 13G OnKure Therapeutics, Filed by: Deep Track Capital, LP
10/10
06:58 pm
okur
Form SC 13G OnKure Therapeutics, Filed by: PERCEPTIVE ADVISORS LLC
Low
Report
Form SC 13G OnKure Therapeutics, Filed by: PERCEPTIVE ADVISORS LLC
10/10
04:31 pm
okur
Form SC 13D/A OnKure Therapeutics, Filed by: Carlyle Group Inc.
Medium
Report
Form SC 13D/A OnKure Therapeutics, Filed by: Carlyle Group Inc.
10/9
04:15 pm
okur
Form 3 OnKure Therapeutics, For: Oct 04 Filed by: ACORN CAPITAL ADVISORS GP, LLC
Low
Report
Form 3 OnKure Therapeutics, For: Oct 04 Filed by: ACORN CAPITAL ADVISORS GP, LLC
10/9
04:02 pm
okur
Form SC 13G OnKure Therapeutics, Filed by: ACORN BIOVENTURES, L.P.
Low
Report
Form SC 13G OnKure Therapeutics, Filed by: ACORN BIOVENTURES, L.P.
10/9
11:41 am
okur
Form SC 13G/A OnKure Therapeutics, Filed by: BML Investment Partners, L.P.
Low
Report
Form SC 13G/A OnKure Therapeutics, Filed by: BML Investment Partners, L.P.
10/9
11:25 am
okur
Form 4 OnKure Therapeutics, For: Oct 07 Filed by: Leonard Braden Michael
Low
Report
Form 4 OnKure Therapeutics, For: Oct 07 Filed by: Leonard Braden Michael
10/8
07:35 pm
okur
Form SC 13D/A OnKure Therapeutics, Filed by: New Enterprise Associates 15, L.P.
Medium
Report
Form SC 13D/A OnKure Therapeutics, Filed by: New Enterprise Associates 15, L.P.
10/8
07:30 pm
okur
Form 4 OnKure Therapeutics, For: Oct 04 Filed by: Saccomano Nicholas A
Medium
Report
Form 4 OnKure Therapeutics, For: Oct 04 Filed by: Saccomano Nicholas A